To the central content area :::

Taipei Exchange

:::
:::HOME > Press Releases > Press Release Detail

TPEx is scheduled to hold a TPEx Listing Review Committee meeting on October 29, 2020 to review the listing application of WELGENE BIOTECH CO.,LTD. (stock code: 6661)

Date:2020/10/26

WELGENE BIOTECH CO.,LTD. is applying for listing on TPEx. At the time of application, the company has capital in the amount of NT$207,042 thousand, its chairman is CHEN FU CHAN, and its recommending securities firms include Mega Securitie and E.Sun Securities.

Consolidated revenue, net profit after tax attributed to shareholders of the parent company and earnings per share of the applicant reports for FY 2019 were NT$417,459 thousand, NT$30,871 thousand, and NT$1.48 respectively. Consolidated revenue, net profit after tax attributed to shareholders of the parent company and earnings per share of the applicant reports for first half of FY 2020 were NT$193,360 thousand, NT$11,134 thousand, and NT$0.53 respectively.